Carnosic Acid

Carnosic Acid

SCHEMBL29390188

CC(C)c1cc2c(c(O)c1O)[C@@]1(C(=O)O)CCCC(C)(C)[C@@H]1CC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 16/20 1.00
▸ BCL9 O00512 3/20 1.00
▸ CTNNB1 P35222 3/20 1.00
▸ ALDH1A1 P00352 2/20 1.00
▸ CYP3A4 P08684 2/20 1.00
▸ MAPT P10636 2/20 1.00
▸ HPGD P15428 2/20 1.00
▸ MEN1 O00255 1/20 1.00
▸ PTGES O14684 1/20 1.00
▸ CYP2C9 P11712 1/20 1.00
▸ PNLIP P16233 1/20 1.00
▸ ALOX12 P18054 1/20 1.00
▸ GSTO1 P78417 1/20 1.00
▸ KMT2A Q03164 1/20 1.00
▸ KDM4E B2RXH2 1/20 1.00
▸ USP2 O75604 1/20 1.00
▸ TP53 P04637 1/20 1.00
▸ MAPK1 P28482 1/20 1.00
▸ HSD17B10 Q99714 1/20 1.00
▸ TDP1 Q9NUW8 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carnosic Acid SCHEMBL12590737 1.00 FDPS (1.00) FDPSBCL9CTNNB1ALDH1A1CYP3A4
Carnosic Acid SCHEMBL13309664 1.00 FDPS (1.00) FDPSBCL9CTNNB1ALDH1A1CYP3A4
Carnosic Acid SCHEMBL18290359 1.00 FDPS (1.00) FDPSBCL9CTNNB1ALDH1A1CYP3A4
Carnosic Acid SCHEMBL9923661 1.00 FDPS (1.00) FDPSBCL9CTNNB1ALDH1A1CYP3A4
SCHEMBL29405917 0.89 FDPS (0.80) FDPSBCL9CTNNB1ALDH1A1CYP3A4
SCHEMBL9923660 0.89 FDPS (0.80) FDPSBCL9CTNNB1ALDH1A1CYP3A4
SCHEMBL15031243 0.89 FDPS (0.80) FDPSBCL9CTNNB1ALDH1A1CYP3A4
Methyl Carnosate SCHEMBL29426661 0.88 FDPS (1.00) FDPSBCL9CTNNB1ALDH1A1CYP3A4
SCHEMBL15031246 0.86 FDPS (0.76) FDPSBCL9CTNNB1ALDH1A1CYP3A4
SCHEMBL1439596 0.83 FDPS (0.71) FDPSBCL9CTNNB1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12492357-B2 Foaming produce washes and methods of dispensing and using the same BEAUMONT PRODUCTS, INC. (US) 2025-12-09 — — US disclosed
WO-2025149995-A2 AN ANALYTE DETECTION METHOD Simed Global Limited (GB) 2025-07-17 — — WO disclosed
CN-114599337-B Cosmetic composition with enhanced color stability 联合利华知识产权控股有限公司 2024-08-13 — — CN disclosed
EP-3950840-B1 POLYALKYLENE CARBONATE-BASED RESIN, AND MOLDED PRODUCT PRODUCED THEREFROM LG CHEMICAL LTD (KR) 2024-06-26 — — EP disclosed
US-20240124798-A1 FOAMING PRODUCE WASHES AND METHODS OF DISPENSING AND USING THE SAME BEAUMONT PRODUCTS, INC. 2024-04-18 — — US disclosed
US-20230180763-A1 NON-CHLORINATED OXIDIZING BIOCIDE CHEMISTRIES, THEIR METHODS OF PRODUCTION, APPLICATION AND METHODS OF FEED THEREOF ECOLAB USA INC. 2023-06-15 — — US disclosed
WO-2023008902-A1 BIODEGRADABLE RESIN COMPOSITION, AND BIODEGRADABLE FILM AND BIODEGRADABLE PRODUCT USING SAME 씨제이제일제당(주) 2023-02-02 — — WO disclosed
US-20230027219-A1 Skin Care Compositions and Methods of Use Thereof UNIGEN, INC. (US) 2023-01-26 — — US disclosed
EP-2897898-B1 C-O-H COMPOUND PROCESSING FOR HYDROGEN OR LIQUID FUEL PRODUCTION PROTON POWER INC (US) 2022-10-19 — — EP disclosed
US-20220323324-A1 COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITY CONOPCO, INC., D/B/A UNILEVER (US) 2022-10-13 — — US disclosed
US-11446225-B2 Skin care compositions and methods of use thereof UNIGEN, INC. (US) 2022-09-20 — — US disclosed
EP-4048410-A1 COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITY Unilever IP Holdings B.V. (NL) 2022-08-31 — — EP disclosed
CN-114599337-A Cosmetic compositions with enhanced color stability 联合利华知识产权控股有限公司 2022-06-07 — — CN disclosed
EP-3950840-A4 POLYALKYLENE CARBONATE-BASED RESIN, AND MOLDED PRODUCT PRODUCED THEREFROM LG CHEM, LTD. (KR) 2022-04-20 — — EP disclosed
CN-110812295-B Infantile tinea-repairing cream 广州瑞誉化工科技有限公司 2022-03-25 — — CN disclosed
EP-3950840-A1 POLYALKYLENE CARBONATE-BASED RESIN, AND MOLDED PRODUCT PRODUCED THEREFROM LG CHEM, LTD. (KR) 2022-02-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027219-A1 Skin Care Compositions and Methods of Use Thereof CUTA, LGALS8, RBP1 FDPS 4632/4885BCL9 2637/4885CTNNB1 2106/4885
US-20230180763-A1 NON-CHLORINATED OXIDIZING BIOCIDE CHEMISTRIES, THEIR METHODS OF PRODUCTION, APPLICATION AND METHODS OF FEED THEREOF CAT, LPO, CBR3 FDPS 1889/4885BCL9 763/4885CTNNB1 4742/4885
US-11446225-B2 Skin care compositions and methods of use thereof CUTA, LGALS8, RBP1 FDPS 4632/4885BCL9 2637/4885CTNNB1 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback